Wolverine Trading
ATYR

Wolverine Trading’s aTyr Pharma ATYR Stock Holding History

Wolverine Trading’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$163K Buy
+205,100
New +$929K ﹤0.01% 5026
2025
Q2 		– Sell
-58,500
Closed -$183K – 5765
2025
Q1 		$183K Buy
+58,500
New +$213K ﹤0.01% 3993
2023
Q4 		– Sell
-10,700
Closed -$16.9K – 5367
2023
Q3 		$16.9K Buy
+10,700
New +$19.8K ﹤0.01% 4340
2021
Q4 		– Sell
-42,900
Closed -$381K – 7039
2021
Q3 		$381K Buy
+42,900
New +$257K ﹤0.01% 4349

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's ATYR Position: Q3 2025 in Review

Wolverine Trading opened a new position in aTyr Pharma (ATYR) in Q3 2025: 54,026 shares worth $43K. The stake represents ﹤0.01% of the portfolio and ranks #5448 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in ATYR as recently as Q1 2025.

Wolverine Trading first reported a position in ATYR in Q1 2022 and has held it in 5 quarters since. The position peaked at $142K in Q1 2025. 103 funds tracked by Wall St. Rank hold ATYR as of Q3 2025.

  • Wolverine Trading held 54,026 shares of aTyr Pharma worth $43K as of Q3 2025.
  • aTyr Pharma was a new Wolverine Trading position in Q3 2025.
  • aTyr Pharma made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5448 holding.
  • Wolverine Trading first reported a position in aTyr Pharma in Q1 2022 and has held it in 5 quarters since.
  • Wolverine Trading's aTyr Pharma position peaked at $142K in Q1 2025.
  • 103 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.